Title of article
Anesthetic Management of COVID-19 Associated Mucormycosis: A Narrative Review
Author/Authors
Ankalagi, Basavaraj Department of anesthesiology - pain medicine and critical care - All India Institute of Medical Sciences, New Delhi, India , Khanna, Punnet Department of anesthesiology - pain medicine and critical care - All India Institute of Medical Sciences, New Delhi, India , Singh, Abhishek Department of anesthesiology - pain medicine and critical care - All India Institute of Medical Sciences, New Delhi, India
Pages
4
From page
339
To page
342
Abstract
Severe COVID-19 disease is currently being managed with glucocorticoids. As a result, there are increasing reports of COVID-19 associated mucormycosis. (CAM) Patients with diabetes mellitus, organ transplant recipients, and in immune-compromised patients either due to cancer chemotherapy or with HIV and AIDS are at high risk of developing CAM. Pharmacotherapy with antifungal agents like Amphotericin B and surgery are the main treatment options. In this narrative review, we will discuss the challenges and anesthetic concern while managing CAM.
Keywords
COVID-19 , associated mucormycosis Airway , Anesthetic concerns
Journal title
Journal of Cellular and Molecular Anesthesia
Serial Year
2021
Record number
2713507
Link To Document